Position in AZN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$3,602,400
New position
Shares Held
18,998
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#436
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OPAL CAPITAL LLC holds $50,865,854 across 8 Drug Manufacturers - General names. AZN ranks #6 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
60,314 | $15,317,946 | |
| 2 | ABBV |
AbbVie Inc.
|
47,900 | $12,053,556 | |
| 3 | GSK |
GSK plc
|
108,899 | $5,708,485 | |
| 4 | SNY |
Sanofi
|
125,869 | $5,369,571 | |
| 5 | LLY |
ELI LILLY & Co
|
3,480 | $4,174,016 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
18,998 | $3,602,400 | |
| 7 | MRK |
Merck & Co., Inc.
|
20,497 | $2,633,864 | |
| 8 | NVS |
Novartis AG
|
12,800 | $2,006,016 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,602,400 | 18,998 | Shares | Sole | 2026-08-05 | |
| No filing history on record for this holder in this stock. | ||||||